Now you will get rid of glasses! With these magical eye drops your eyes will change, your vision will become sharp

In the coming times, the need to wear glasses may end. A new eye medicine has brought a revolution. Mumbai-based company Antod Pharmaceuticals has launched Preview Eye Drops which treat presbyopia.

In the coming times, the need to wear glasses may end. A new eye medicine has brought about a revolution. Mumbai-based company Antod Pharmaceuticals has launched Preview Eye Drops which treat presbyopia. Presbyopia is a condition in which people have difficulty focusing on close objects. Around 109 to 180 crore people around the world suffer from this problem. Presbyopia usually starts after the age of 40 and increases till the age of 60.

Antode Pharmaceuticals has received final approval from the Drug Controller General of India (DCGI). Earlier, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) had also recommended this product. Preview is the first eye medicine in India that can reduce the need for reading glasses for people suffering from presbyopia. This is a common age-related vision problem that affects people over 40.

Patent Application for Unique Formulation

Antode Pharmaceuticals has applied for a patent for this unique formulation and its manufacturing process. This proprietary formulation not only eliminates the need for reading glasses but also provides the added benefit of lubricating the eyes.

Cutting-edge technology

Pressview eye drops feature an advanced Dynamic Buffer Technology, which allows them to rapidly adapt to the pH of tears, ensuring consistent efficacy and safety for long-term use. Since these drops may be used for years, this feature is particularly important.

It can significantly affect

daily life and productivity. Preview offers a non-invasive option for people over 40 who may notice this condition when they start reading material at arm's length.

Nikhil K Masurkar, CEO, Antod Pharmaceuticals,

highlighted the significance of this approval and said that PressView is the result of years of dedicated research and development. PressView is not just a product; it is a solution that stands to improve the lives of millions of people, giving them more visual freedom.

How much will it cost?

Dr Aditya Sethi said that Presview can provide an advanced option that improves near vision within 15 minutes. From the first week of October, the prescription-based eye medicine will be available in pharmacies at a cost of Rs 350. This medicine is for the treatment of mild to moderate presbyopia in persons aged 40 to 55 years.